US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist
  • 0.969
  • +0.069+7.70%
Close Aug 23 16:00 ET
  • 0.968
  • -0.001-0.08%
Post 20:02 ET
32.07MMarket Cap-734P/E (TTM)

Reviva Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-44.60%6.18M
6.38%11.97M
26.18%23.37M
26.18%23.37M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
-37.62%18.52M
-30.75%23.19M
-Cash and cash equivalents
-44.60%6.18M
6.38%11.97M
26.18%23.37M
26.18%23.37M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
-37.62%18.52M
-30.75%23.19M
Prepaid assets
--528.95K
--779.6K
----
----
----
----
----
----
----
----
Other current assets
-23.84%525.83K
-54.84%743.38K
-17.55%332.93K
-17.55%332.93K
-51.15%414.74K
-43.56%690.44K
-10.89%1.65M
-76.47%403.82K
-76.47%403.82K
111.03%849.02K
Total current assets
-38.92%7.23M
4.61%13.5M
25.24%23.7M
25.24%23.7M
-77.59%5.39M
-42.64%11.84M
-48.94%12.9M
-39.74%18.92M
-39.74%18.92M
-29.07%24.04M
Non current assets
Non current prepaid assets
--819.72K
----
----
----
----
----
----
----
----
----
Total non current assets
--819.72K
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-32.00%8.05M
4.61%13.5M
25.24%23.7M
25.24%23.7M
-77.59%5.39M
-42.64%11.84M
-48.94%12.9M
-39.74%18.92M
-39.74%18.92M
-29.07%24.04M
Liabilities
Current liabilities
Payables
77.22%4.69M
99.98%5.72M
9.34%3.85M
9.34%3.85M
124.82%5.28M
3.72%2.65M
100.62%2.86M
590.81%3.52M
590.81%3.52M
457.96%2.35M
-accounts payable
77.22%4.69M
99.98%5.72M
9.34%3.85M
9.34%3.85M
124.82%5.28M
3.72%2.65M
100.62%2.86M
590.81%3.52M
590.81%3.52M
457.96%2.35M
Current accrued expenses
22.24%7.75M
138.22%7.22M
110.43%12.37M
110.43%12.37M
513.40%7.53M
229.37%6.34M
37.97%3.03M
220.24%5.88M
220.24%5.88M
122.08%1.23M
Current debt and capital lease obligation
-6.74%207.5K
-50.26%332K
----
----
--222.5K
--222.5K
--667.5K
----
----
----
-Current debt
-6.74%207.5K
-50.26%332K
----
----
--222.5K
--222.5K
--667.5K
----
----
----
Current liabilities
51.43%13.94M
120.91%14.49M
72.41%17.18M
72.41%17.18M
264.49%13.03M
105.66%9.21M
81.05%6.56M
324.85%9.96M
324.85%9.96M
267.23%3.58M
Non current liabilities
Derivative product liabilities
-85.16%150.21K
-37.00%350.48K
42.16%806.66K
42.16%806.66K
726.32%873.41K
857.90%1.01M
96.08%556.31K
52.24%567.44K
52.24%567.44K
-83.76%105.7K
Total non current liabilities
-85.16%150.21K
-37.00%350.48K
42.16%806.66K
42.16%806.66K
726.32%873.41K
857.90%1.01M
96.08%556.31K
52.24%567.44K
52.24%567.44K
-83.76%105.7K
Total liabilities
37.90%14.09M
108.56%14.84M
70.78%17.98M
70.78%17.98M
277.75%13.91M
123.01%10.22M
82.14%7.12M
287.46%10.53M
287.46%10.53M
126.61%3.68M
Shareholders'equity
Share capital
31.66%2.98K
36.53%2.79K
36.53%2.79K
36.53%2.79K
10.81%2.27K
49.70%2.27K
35.16%2.05K
41.72%2.05K
41.72%2.05K
52.77%2.04K
-common stock
31.66%2.98K
36.53%2.79K
36.53%2.79K
36.53%2.79K
10.81%2.27K
49.70%2.27K
35.16%2.05K
41.72%2.05K
41.72%2.05K
52.77%2.04K
-Preferred stock
--0
--0
--0
--0
----
----
----
--0
--0
----
Retained earnings
-35.78%-149.65M
-45.02%-141.79M
-41.29%-134.35M
-41.29%-134.35M
-45.34%-120.71M
-38.57%-110.22M
-31.78%-97.77M
-42.29%-95.09M
-42.29%-95.09M
-31.52%-83.05M
Paid-in capital
28.41%143.6M
35.62%140.44M
35.35%140.07M
35.35%140.07M
8.49%112.19M
16.99%111.84M
8.37%103.56M
8.34%103.49M
8.34%103.49M
8.38%103.41M
Total stockholders'equity
-472.66%-6.04M
-123.26%-1.35M
-31.87%5.72M
-31.87%5.72M
-141.84%-8.52M
-89.91%1.62M
-72.92%5.78M
-70.74%8.39M
-70.74%8.39M
-36.91%20.36M
Total equity
-472.66%-6.04M
-123.26%-1.35M
-31.87%5.72M
-31.87%5.72M
-141.84%-8.52M
-89.91%1.62M
-72.92%5.78M
-70.74%8.39M
-70.74%8.39M
-36.91%20.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -44.60%6.18M6.38%11.97M26.18%23.37M26.18%23.37M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M-37.62%18.52M-30.75%23.19M
-Cash and cash equivalents -44.60%6.18M6.38%11.97M26.18%23.37M26.18%23.37M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M-37.62%18.52M-30.75%23.19M
Prepaid assets --528.95K--779.6K--------------------------------
Other current assets -23.84%525.83K-54.84%743.38K-17.55%332.93K-17.55%332.93K-51.15%414.74K-43.56%690.44K-10.89%1.65M-76.47%403.82K-76.47%403.82K111.03%849.02K
Total current assets -38.92%7.23M4.61%13.5M25.24%23.7M25.24%23.7M-77.59%5.39M-42.64%11.84M-48.94%12.9M-39.74%18.92M-39.74%18.92M-29.07%24.04M
Non current assets
Non current prepaid assets --819.72K------------------------------------
Total non current assets --819.72K--0--0--0--0--0--0--0--0--0
Total assets -32.00%8.05M4.61%13.5M25.24%23.7M25.24%23.7M-77.59%5.39M-42.64%11.84M-48.94%12.9M-39.74%18.92M-39.74%18.92M-29.07%24.04M
Liabilities
Current liabilities
Payables 77.22%4.69M99.98%5.72M9.34%3.85M9.34%3.85M124.82%5.28M3.72%2.65M100.62%2.86M590.81%3.52M590.81%3.52M457.96%2.35M
-accounts payable 77.22%4.69M99.98%5.72M9.34%3.85M9.34%3.85M124.82%5.28M3.72%2.65M100.62%2.86M590.81%3.52M590.81%3.52M457.96%2.35M
Current accrued expenses 22.24%7.75M138.22%7.22M110.43%12.37M110.43%12.37M513.40%7.53M229.37%6.34M37.97%3.03M220.24%5.88M220.24%5.88M122.08%1.23M
Current debt and capital lease obligation -6.74%207.5K-50.26%332K----------222.5K--222.5K--667.5K------------
-Current debt -6.74%207.5K-50.26%332K----------222.5K--222.5K--667.5K------------
Current liabilities 51.43%13.94M120.91%14.49M72.41%17.18M72.41%17.18M264.49%13.03M105.66%9.21M81.05%6.56M324.85%9.96M324.85%9.96M267.23%3.58M
Non current liabilities
Derivative product liabilities -85.16%150.21K-37.00%350.48K42.16%806.66K42.16%806.66K726.32%873.41K857.90%1.01M96.08%556.31K52.24%567.44K52.24%567.44K-83.76%105.7K
Total non current liabilities -85.16%150.21K-37.00%350.48K42.16%806.66K42.16%806.66K726.32%873.41K857.90%1.01M96.08%556.31K52.24%567.44K52.24%567.44K-83.76%105.7K
Total liabilities 37.90%14.09M108.56%14.84M70.78%17.98M70.78%17.98M277.75%13.91M123.01%10.22M82.14%7.12M287.46%10.53M287.46%10.53M126.61%3.68M
Shareholders'equity
Share capital 31.66%2.98K36.53%2.79K36.53%2.79K36.53%2.79K10.81%2.27K49.70%2.27K35.16%2.05K41.72%2.05K41.72%2.05K52.77%2.04K
-common stock 31.66%2.98K36.53%2.79K36.53%2.79K36.53%2.79K10.81%2.27K49.70%2.27K35.16%2.05K41.72%2.05K41.72%2.05K52.77%2.04K
-Preferred stock --0--0--0--0--------------0--0----
Retained earnings -35.78%-149.65M-45.02%-141.79M-41.29%-134.35M-41.29%-134.35M-45.34%-120.71M-38.57%-110.22M-31.78%-97.77M-42.29%-95.09M-42.29%-95.09M-31.52%-83.05M
Paid-in capital 28.41%143.6M35.62%140.44M35.35%140.07M35.35%140.07M8.49%112.19M16.99%111.84M8.37%103.56M8.34%103.49M8.34%103.49M8.38%103.41M
Total stockholders'equity -472.66%-6.04M-123.26%-1.35M-31.87%5.72M-31.87%5.72M-141.84%-8.52M-89.91%1.62M-72.92%5.78M-70.74%8.39M-70.74%8.39M-36.91%20.36M
Total equity -472.66%-6.04M-123.26%-1.35M-31.87%5.72M-31.87%5.72M-141.84%-8.52M-89.91%1.62M-72.92%5.78M-70.74%8.39M-70.74%8.39M-36.91%20.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg